Skip to main content
SpringerLink
Log in

Overexpression of Her2/neu, estrogen and progesterone receptors in invasive micropapillary carcinoma of the breast

  • Short Paper
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

Background

Invasive micropapillary carcinoma (IMC) of the breast is a rare subtype of breast carcinoma that has an extremely high incidence of lymph node metastasis and poor clinical outcome. Furthermore, there has been interest in the prognostic markers related to the biological characteristics of breast carcinoma, such as the status of Her2/neu, estrogen receptor (ER) and progesterone receptor (PgR).

Materials and Methods

We reviewed 671 cases of primary breast carcinoma which were surgically resected between 1990 and 2003. Of these, 27 cases of invasive ductal carcinoma of the breast with a pure or partial micropapillary component were reported. Tests for Her2/neu protein, estrogen receptor (ER) and progesterone receptor (PgR) were performed on paraffin sections. The relationship among these markers was analyzed and statistical significance determined by chi-square test.

Conclusion

The rate of Her2/neu protein overexpression, ER and PgR status was quite similar to those of common breast carcinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fisher ER, Palekar AS, Redmond C, Barton B, Fisher B: Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol no.4). IV. Invasive papillary cancer.Am J Clin Pathol 73:313–321, 1980.

    PubMed  CAS  Google Scholar 

  2. Siriaunkgul S, Tavassoli FA: Invasive micropapillary carcinoma of the breast.Mod Pathol 6:660–663, 1993.

    PubMed  CAS  Google Scholar 

  3. Luna-More S, Gonzalez B, Acedo C, Rodrigo I, Luna C: Invasive micropapillary carcinoma of the breast. A new special type of invasive mammary carcinoma.Pathol Res Pract 190:668–674, 1994.

    PubMed  CAS  Google Scholar 

  4. Luna-More S, de los Santos F, Breton JJ, Canadas MA: Estrogen and progesterone receptors, c-erb-2, p-53, and Bcl-2 in thirty-three invasive micropapillary breast carcinomas.Pathol Res Pract 92:27–32, 1996.

    Google Scholar 

  5. Middleton LP, Tressera F, Sobel ME, Bryant BR, Alburquerque A, Grases P, Merino MJ: Infiltrating micropapillary carcinoma of the breast.Mod Pathol 12:499–504, 1999.

    PubMed  CAS  Google Scholar 

  6. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.Science 235:177–182, 1987.

    Article  PubMed  CAS  Google Scholar 

  7. Yokota J, Yamamoto T, Miyajima N, Toyoshima K, Nomura N, Sakamoto H, Yoshida T, Terada M, Sugimura T: Genetic alterations of the c-erb-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbAhomologue.Oncogene 2:283–287, 1988.

    PubMed  CAS  Google Scholar 

  8. Yoshida K, Tsuda T, Matsumura T, Tsujino T, Hattori T, Ito H, Tahara E: Amplification of epidermal growth factor receptor (EGFR) gene and oncogenes in human gastric carcinomas.Virchows Arch 57:285–290, 1989.

    Article  CAS  Google Scholar 

  9. Hou L, Shi D, Tu SM, Zhang HZ, Hung MC, Ling D: Oral cancer progression and c-erb-2/neu proto-onco-gene expression.Cancer Lett 65:215–220, 1992.

    Article  PubMed  CAS  Google Scholar 

  10. Xia W, Lau YK, Zhang HZ, Liu AR, Li L, Kiyokawa N, Clayman GL, Katz RL, Hung MC: Strong correlation between c-erb-2 overexpression and overall survival of patients with oral squamous cell carcinoma.Clin Cancer Res 3:3–9, 1997.

    PubMed  CAS  Google Scholar 

  11. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, Soper JT, Dodge R, Clarke-Pearson DL, Marks P: Overexpression of HER2/neu is associated with poor survival in advanced epithelial ovarian cancer.Cancer Res 50:4087–4091, 1990.

    PubMed  CAS  Google Scholar 

  12. Zhang X, Silva E, Gershenson D, Hung MC: Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract. 4:985–989, 1989.

  13. Schneider PM, Hung MC, Chiocca SM, Manning J, Zhao XY, Fang K, Roth JA: Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.Cancer Res 49:4968–4971, 1989.

    PubMed  CAS  Google Scholar 

  14. Luna-More S, Casquero S, Perez-Mellado A, Rius F, Weill B, Gornemann I: Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow-up of 54.Pathol Res Pract 196:35–39, 2000.

    PubMed  CAS  Google Scholar 

  15. Akiyama F: Essential breast pathology, and the differential diagnosis II, Invasive micropapillary carcinoma.Pathol Clin Med 19:474–476, 2001 (in Japanese, English abstract).

    Google Scholar 

  16. Tressera F, Grases PJ, Fabregas R, Fernandez-Cid A, Dexeus S: Invasive micropapillary breast carcinomas.Pathol Res Pract 92:27–32, 1996.

    Google Scholar 

  17. Peterson JL: Breast carcinomas with unexpected inside out growth pattern. Rotation of polarization associated with angioinvasion.Pathol Res Pract 189:780A, 1993.

    Google Scholar 

  18. Tsumagari K, Sakamoto G, Akiyama F, Kasumi F: The pathological diagnosis and clinical significance of invasive micropapillary carcinoma of the breast.Jpn J Breast Cancer 16:441–446, 2001 (in Japanese with English abstract).

    Google Scholar 

  19. Tsumagari K, Sakamoto G, Akiyama F, Kasumi F: The clinicopathological study of invasive micropapillary carcinoma of the breast.Jpn J Breast Cancer 16:341–348, 2001 (in Japanese with English abstract).

    Google Scholar 

  20. Paterakaos M, Watkin WG, Edgerton SM, Moore DH, Thor AD: Invasive micropapillary carcinoma of the breast: a prognostic study.Hum Pathol 30:1459–1463, 1999.

    Article  Google Scholar 

  21. Nassar H, Wallis BS, Andea A, Dey J, Adsay V, Visscher D: Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma.Mod Pathol 14:836–841, 2001.

    Article  PubMed  CAS  Google Scholar 

  22. Stern DF, Heffernan PA, Weinberg RA: P185, a product of the neu proto-oncogene, is a receptor like protein associated with tyrosine kinase activity.Mol Cell Biol 6:1729–1740, 1986.

    PubMed  CAS  Google Scholar 

  23. Walsh MM, Bleiweiss IJ: Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity.Hum Pathol 32:583–589, 2001.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Saitama Medical Center, Saitama Medical School, Japan

    Hajime Kuroda & Shinji Itoyama

  2. Department of Surgery, Saitama Medical Center, Saitama Medical School, Japan

    Kiyoshi Ohnisi

  3. Department of Breast Pathology, Cancer Institute, and Hospital, Japanese Foundation for Cancer Research, Japan

    Goi Sakamoto

Authors
  1. Hajime Kuroda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Goi Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kiyoshi Ohnisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shinji Itoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hajime Kuroda.

About this article

Cite this article

Kuroda, H., Sakamoto, G., Ohnisi, K. et al. Overexpression of Her2/neu, estrogen and progesterone receptors in invasive micropapillary carcinoma of the breast. Breast Cancer 11, 301–305 (2004). https://doi.org/10.1007/BF02984553

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02984553

Key words

Search

Navigation